BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2763022)

  • 1. The content of tumor DNA as an indicator of prognosis in patients with T1N0M0 and T2N0M0 carcinoma of the breast.
    Ellis CN; Frey ES; Burnette JJ; Akin JM; Reading C; Gaskin TA; Blakemore WS
    Surgery; 1989 Aug; 106(2):133-8. PubMed ID: 2763022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the nuclear DNA content and the prognosis in squamous cell carcinoma of the lung].
    Yamaoka N; Uchiyama Y; Kimino K; Akamine S; Matsuo S
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Aug; 38(8):1284-90. PubMed ID: 2230383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
    Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
    Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric detection of multifocal DNA aneuploid cell populations in mastectomy specimens containing a primary breast carcinoma.
    van Dam PA; Van Bockstaele DR; Keersmaeckers GH; Uyttenbroeck FL
    Cytometry; 1990; 11(2):300-7. PubMed ID: 2318083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma.
    Iwao Y; Kim YI; Kaketani K; Nakashima K; Okada K; Kobayashi M
    Hepatogastroenterology; 1993 Oct; 40(5):491-5. PubMed ID: 8270242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
    Hedley DW; Friedlander ML; Taylor IW
    Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.
    Ewers SB; Långström E; Baldetorp B; Killander D
    Cytometry; 1984 Jul; 5(4):408-19. PubMed ID: 6468179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
    Pinto AE; Pereira T; Silva GL; André S
    Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance].
    Liewald F; Sunder-Plassmann L; Valet G; Wulf G; Weiss M; Schildberg FW
    Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
    Rosen PP; Groshen S; Kinne DW
    J Clin Oncol; 1991 Sep; 9(9):1650-61. PubMed ID: 1875222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.